Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning.

Martti Juhola1, Kirsi Penttinen2, Henry Joutsijoki3

  • 1Faculty of Information Technology and Communication Sciences, Tampere University, Tampere, Finland. Martti.Juhola@tuni.fi.

Summary

Machine learning analyzes patient-specific stem cell-derived cardiomyocytes (iPSC-CMs) to predict drug effects for inherited heart conditions like CPVT. This approach shows promise for personalized medicine and efficient drug screening.